V1.3: Чтение
I:
S: Прочтите текст. Укажите предложение, которое не соответствует содержанию текста.
Werner Arber (1929-). Swiss microbiologist and geneticist. Shared the 1978 Nobel Prize in Physiology or Medicine with Hamilton Smith and Daniel Nathans for the discovery of restriction endonucleases, which led to the development of recombinant DNA technology.
For their 1970 discovery of restriction endonucleases (often called by the shorter name restriction enzymes) Werner Arber, Hamilton Smith, and Daniel Nathans received the 1978 Nobel Prize for Physiology or Medicine. Restriction enzymes are produced by bacteria, in which they function as a simple immune system — A restriction enzyme protects the bacterium producing it from viral infection by chopping up invading viruses, which are composed of either RNA or DNA.
-: Werner Arber is a Swiss microbiologist and geneticist.
-: In 1970 he discovered the structure of DNA.
-: He received the Nobel Prize for the discovery of restriction endonucleases.
I: S: Прочтите текст. Укажите предложение, которое соответствует содержанию текста.
Werner Arber (1929-). Swiss microbiologist and geneticist. Shared the 1978 Nobel Prize in Physiology or Medicine with Hamilton Smith and Daniel Nathans for the discovery of restriction endonucleases, which led to the development of recombinant DNA technology.
For their 1970 discovery of restriction endonucleases (often called by the shorter name restriction enzymes) Werner Arber, Hamilton Smith, and Daniel Nathans received the 1978 Nobel Prize for Physiology or Medicine. Restriction enzymes are produced by bacteria, in which they function as a simple immune system — A restriction enzyme protects the bacterium producing it from viral infection by chopping up invading viruses, which are composed of either RNA or DNA.
-: He shared the 1978 Nobel Prize in Anatomy or Medicine with Hamilton Smith and Daniel Nathans.
-:Werner Arber is a German microbiologist and geneticist.
-: The discovery of restriction endonucleases led to the development of recombinant DNA technology.
I:
S: Прочтите текст. Укажите предложение , которое не соответствует содержанию текста:
Drug Discovery and Biochemistry.
Biomedical research gives scientists the platform to create sophisticated new drugs that will act with great precision. Research into monoclonal antibodies - discovered in Cambridge by George Kohler and Cesar Milstein - has revolutionised treatments for cancer. These are the so-called 'next generation' treatments for life-threatening conditions.
An explosion in understanding of the molecular circuits controlling normal and diseased cells has identified many potential targets for the latest medicines. A multidisciplinary initiative, the Cambridge Molecular Therapeutics Programme (CMTP), directed by Professors Ashok Venkitaraman and Tom Blundell, seeks to pioneer methods for the discovery and development of next-generation drugs.
CMTP brings together expertise in physical, chemical and biomedical sciences to develop new approaches to drug discovery. The programme welcomes partnerships with commercial collaborators.
-: Research into monoclonal antibodies has revolutionised treatments for cancer .
-: The programme welcomes partnerships with commercial collaborators.
-:. Biomedical research gives scientists the platform to create sophisticated new methods of treatment that will act with great precision.
I:
S: Прочтите текст. Укажите предложение, которое соответствует содержанию текста:
Drug Discovery and Biochemistry.
Biomedical research gives scientists the platform to create sophisticated new drugs that will act with great precision. Research into monoclonal antibodies - discovered in Cambridge by George Kohler and Cesar Milstein - has revolutionised treatments for cancer. These are the so-called 'next generation' treatments for life-threatening conditions.
An explosion in understanding of the molecular circuits controlling normal and diseased cells has identified many potential targets for the latest medicines. A multidisciplinary initiative, the Cambridge Molecular Therapeutics Programme (CMTP), directed by Professors Ashok Venkitaraman and Tom Blundell, seeks to pioneer methods for the discovery and development of next-generation drugs.
CMTP brings together expertise in physical, chemical and biomedical sciences to develop new approaches to drug discovery. The programme welcomes partnerships with commercial collaborators.
-: George Kohler and Cesar Milstein discovered monoclonal antibodies.
-: Biomedical research gives scientists the platform to create sophisticated new methods of treatment that will act with great precision.
-: Cesar Milstein directs the Cambridge Molecular Therapeutics Programme (CMTP).